Structure of a nanobody-stabilized active state of the β2 adrenoceptor
10.1038/nature09648
Crossref journal-article
Springer Science and Business Media LLC
Nature (297)
Bibliography

Rasmussen, S. G. F., Choi, H.-J., Fung, J. J., Pardon, E., Casarosa, P., Chae, P. S., DeVree, B. T., Rosenbaum, D. M., Thian, F. S., Kobilka, T. S., Schnapp, A., Konetzki, I., Sunahara, R. K., Gellman, S. H., Pautsch, A., Steyaert, J., Weis, W. I., & Kobilka, B. K. (2011). Structure of a nanobody-stabilized active state of the β2 adrenoceptor. Nature, 469(7329), 175–180.

Authors 18
  1. Søren G. F. Rasmussen (first)
  2. Hee-Jung Choi (additional)
  3. Juan Jose Fung (additional)
  4. Els Pardon (additional)
  5. Paola Casarosa (additional)
  6. Pil Seok Chae (additional)
  7. Brian T. DeVree (additional)
  8. Daniel M. Rosenbaum (additional)
  9. Foon Sun Thian (additional)
  10. Tong Sun Kobilka (additional)
  11. Andreas Schnapp (additional)
  12. Ingo Konetzki (additional)
  13. Roger K. Sunahara (additional)
  14. Samuel H. Gellman (additional)
  15. Alexander Pautsch (additional)
  16. Jan Steyaert (additional)
  17. William I. Weis (additional)
  18. Brian K. Kobilka (additional)
References 32 Referenced 1,516
  1. Rosenbaum, D. M., Rasmussen, S. G. & Kobilka, B. K. The structure and function of G-protein-coupled receptors. Nature 459, 356–363 (2009) (10.1038/nature08144) / Nature by DM Rosenbaum (2009)
  2. Scheerer, P. et al. Crystal structure of opsin in its G-protein-interacting conformation. Nature 455, 497–502 (2008) (10.1038/nature07330) / Nature by P Scheerer (2008)
  3. Park, J. H., Scheerer, P., Hofmann, K. P., Choe, H. W. & Ernst, O. P. Crystal structure of the ligand-free G-protein-coupled receptor opsin. Nature 454, 183–187 (2008) (10.1038/nature07063) / Nature by JH Park (2008)
  4. Li, J., Edwards, P. C., Burghammer, M., Villa, C. & Schertler, G. F. Structure of bovine rhodopsin in a trigonal crystal form. J. Mol. Biol. 343, 1409–1438 (2004) (10.1016/j.jmb.2004.08.090) / J. Mol. Biol. by J Li (2004)
  5. Palczewski, K. et al. Crystal structure of rhodopsin: a G protein-coupled receptor. Science [see comments]. 289, 739–745 (2000) (10.1126/science.289.5480.739) / Science by K. Palczewski (2000)
  6. Vogel, R. & Siebert, F. Conformations of the active and inactive states of opsin. J. Biol. Chem. 276, 38487–38493 (2001) (10.1074/jbc.M105423200) / J. Biol. Chem. by R Vogel (2001)
  7. Rosenbaum, D. M. et al. GPCR engineering yields high-resolution structural insights into β-adrenergic receptor function. Science 318, 1266–1273 (2007) (10.1126/science.1150609) / Science by DM Rosenbaum (2007)
  8. Rasmussen, S. G. et al. Crystal structure of the human β2 adrenergic G-protein-coupled receptor. Nature 450, 383–387 (2007) (10.1038/nature06325) / Nature by SG Rasmussen (2007)
  9. Cherezov, V. et al. High-resolution crystal structure of an engineered human β2-adrenergic G protein-coupled receptor. Science 318, 1258–1265 (2007) (10.1126/science.1150577) / Science by V Cherezov (2007)
  10. Hanson, M. A. et al. A specific cholesterol binding site is established by the 2.8 Å structure of the human β2-adrenergic receptor. Structure 16, 897–905 (2008) (10.1016/j.str.2008.05.001) / Structure by MA Hanson (2008)
  11. Warne, T. et al. Structure of a β1-adrenergic G-protein-coupled receptor. Nature 454, 486–491 (2008) (10.1038/nature07101) / Nature by T Warne (2008)
  12. Jaakola, V. P. et al. The 2.6 Angstrom crystal structure of a human A2A adenosine receptor bound to an antagonist. Science 322, 1211–1217 (2008) (10.1126/science.1164772) / Science by VP Jaakola (2008)
  13. Ghanouni, P. et al. Functionally different agonists induce distinct conformations in the G protein coupling domain of the β2 adrenergic receptor. J. Biol. Chem. 276, 24433–24436 (2001) (10.1074/jbc.C100162200) / J. Biol. Chem. by P Ghanouni (2001)
  14. Rosenbaum, D. M. et al. Structure and function of an irreversible agonist–β2 adrenoceptor complex. Nature doi:10.1038/nature09665 (this issue). (10.1038/nature09665)
  15. Yao, X. J. et al. The effect of ligand efficacy on the formation and stability of a GPCR-G protein complex. Proc. Natl Acad. Sci. USA 106, 9501–9506 (2009) (10.1073/pnas.0811437106) / Proc. Natl Acad. Sci. USA by XJ Yao (2009)
  16. Hamers-Casterman, C. et al. Naturally occurring antibodies devoid of light chains. Nature 363, 446–448 (1993) (10.1038/363446a0) / Nature by C Hamers-Casterman (1993)
  17. Ballesteros, J. A. & Weinstein, H. Integrated methods for the construction of three-dimensional models and computational probing of structure-function relations in G protein coupled receptors. Meth. Neurosci. 25, 366–428 (1995) (10.1016/S1043-9471(05)80049-7) / Meth. Neurosci. by JA Ballesteros (1995)
  18. Strader, C. D. et al. Identification of residues required for ligand binding to the β-adrenergic receptor. Proc. Natl Acad. Sci. USA 84, 4384–4388 (1987) (10.1073/pnas.84.13.4384) / Proc. Natl Acad. Sci. USA by CD Strader (1987)
  19. Liapakis, G. et al. The forgotten serine. A critical role for Ser-2035.42 in ligand binding to and activation of the β2-adrenergic receptor. J. Biol. Chem. 275, 37779–37788 (2000) (10.1074/jbc.M002092200) / J. Biol. Chem. by G Liapakis (2000)
  20. Wieland, K., Zuurmond, H. M., Krasel, C., Ijzerman, A. P. & Lohse, M. J. Involvement of Asn-293 in stereospecific agonist recognition and in activation of the beta 2-adrenergic receptor. Proc. Natl Acad. Sci. USA 93, 9276–9281 (1996) (10.1073/pnas.93.17.9276) / Proc. Natl Acad. Sci. USA by K Wieland (1996)
  21. Shi, L. et al. β2 adrenergic receptor activation. Modulation of the proline kink in transmembrane 6 by a rotamer toggle switch. J. Biol. Chem. 277, 40989–40996 (2002) (10.1074/jbc.M206801200) / J. Biol. Chem. by L Shi (2002)
  22. Ahuja, S. & Smith, S. O. Multiple switches in G protein-coupled receptor activation. Trends Pharmacol. Sci. 30, 494–502 (2009) (10.1016/j.tips.2009.06.003) / Trends Pharmacol. Sci. by S Ahuja (2009)
  23. Pellissier, L. P. et al. Conformational toggle switches implicated in basal constitutive and agonist-induced activated states of 5-hydroxytryptamine-4 receptors. Mol. Pharmacol. 75, 982–990 (2009) (10.1124/mol.108.053686) / Mol. Pharmacol. by LP Pellissier (2009)
  24. Altenbach, C., Kusnetzow, A. K., Ernst, O. P., Hofmann, K. P. & Hubbell, W. L. High-resolution distance mapping in rhodopsin reveals the pattern of helix movement due to activation. Proc. Natl Acad. Sci. USA 105, 7439–7444 (2008) (10.1073/pnas.0802515105) / Proc. Natl Acad. Sci. USA by C Altenbach (2008)
  25. Parnot, C., Miserey-Lenkei, S., Bardin, S., Corvol, P. & Clauser, E. Lessons from constitutively active mutants of G protein-coupled receptors. Trends Endocrinol. Metab. 13, 336–343 (2002) (10.1016/S1043-2760(02)00628-8) / Trends Endocrinol. Metab. by C Parnot (2002)
  26. Kobilka, B. K. Amino and carboxyl terminal modifications to facilitate the production and purification of a G protein-coupled receptor. Anal. Biochem. 231, 269–271 (1995) (10.1006/abio.1995.1533) / Anal. Biochem. by BK Kobilka (1995)
  27. Caffrey, M. & Cherezov, V. Crystallizing membrane proteins using lipidic mesophases. Nature Protocols 4, 706–731 (2009) (10.1038/nprot.2009.31) / Nature Protocols by M Caffrey (2009)
  28. Otwinowski, Z. & Minor, W. Processing of X-ray diffraction data collected in oscillation mode. Methods Enzymol. 276, 307–326 (1997) (10.1016/S0076-6879(97)76066-X) / Methods Enzymol. by Z Otwinowski (1997)
  29. McCoy, A. J. et al. Phaser crystallographic software. J. Appl. Cryst. 40, 658–674 (2007) (10.1107/S0021889807021206) / J. Appl. Cryst. by AJ McCoy (2007)
  30. Afonine, P. V., Grosse-Kunstleve, R. W. & Adams, P. D. A robust bulk-solvent correction and anisotropic scaling procedure. Acta Crystallogr. D 61, 850–855 (2005) (10.1107/S0907444905007894) / Acta Crystallogr. D by PV Afonine (2005)
  31. Blanc, E. et al. Refinement of severely incomplete structures with maximum likelihood in BUSTER-TNT . Acta Crystallogr. D 60, 2210–2221 (2004) (10.1107/S0907444904016427) / Acta Crystallogr. D by E Blanc (2004)
  32. Whorton, M. R. et al. A monomeric G protein-coupled receptor isolated in a high-density lipoprotein particle efficiently activates its G protein. Proc. Natl Acad. Sci. USA 104, 7682–7687 (2007) (10.1073/pnas.0611448104) / Proc. Natl Acad. Sci. USA by MR Whorton (2007)
Dates
Type When
Created 14 years, 7 months ago (Jan. 11, 2011, 3:46 p.m.)
Deposited 2 years, 3 months ago (May 18, 2023, 1:49 p.m.)
Indexed 2 days, 3 hours ago (Aug. 29, 2025, 6:45 a.m.)
Issued 14 years, 7 months ago (Jan. 1, 2011)
Published 14 years, 7 months ago (Jan. 1, 2011)
Published Online 14 years, 7 months ago (Jan. 12, 2011)
Published Print 14 years, 7 months ago (Jan. 1, 2011)
Funders 0

None

@article{Rasmussen_2011, title={Structure of a nanobody-stabilized active state of the β2 adrenoceptor}, volume={469}, ISSN={1476-4687}, url={http://dx.doi.org/10.1038/nature09648}, DOI={10.1038/nature09648}, number={7329}, journal={Nature}, publisher={Springer Science and Business Media LLC}, author={Rasmussen, Søren G. F. and Choi, Hee-Jung and Fung, Juan Jose and Pardon, Els and Casarosa, Paola and Chae, Pil Seok and DeVree, Brian T. and Rosenbaum, Daniel M. and Thian, Foon Sun and Kobilka, Tong Sun and Schnapp, Andreas and Konetzki, Ingo and Sunahara, Roger K. and Gellman, Samuel H. and Pautsch, Alexander and Steyaert, Jan and Weis, William I. and Kobilka, Brian K.}, year={2011}, month=jan, pages={175–180} }